Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - EPS
EPS CRVS - Corvus Pharmaceuticals, Inc.
-0.56
LAST VALUE
21.55%
2 YEAR CAGR
20.01%
5 YEAR CAGR
0.00%
10 YEAR CAGR